Long-term treatment with tetrahydrobiopterin in phenylketonuria: Treatment strategies and prediction of long-term responders

Molecular Genetics and Metabolism

Volumn 107, Issue 3, 2012, Pages 294-301

  Hennermann, Julia B ^a   Roloff, Sylvia ^a   Gebauer, Christine ^a   Vetter, Barbara ^a   von Arnim Baas, Annabel ^a   Mönch, Eberhard ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Hyperphenylalaninemia; Phenylketonuria; Sapropterin; Tetrahydrobiopterin

Indexed keywords

PHENYLALANINE; TETRAHYDROBIOPTERIN; TYROSINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; DRUG DOSE REDUCTION; FEMALE; GENOTYPE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHENOTYPE; PHENYLKETONURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; BIOMARKERS, PHARMACOLOGICAL; BIOPTERIN; CHILD; CHILD, PRESCHOOL; DISEASE MANAGEMENT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LONG-TERM CARE; MALE; PHENYLALANINE; PHENYLALANINE HYDROXYLASE; PHENYLKETONURIAS; PROGNOSIS; TYROSINE;

EID: 84867901717     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2012.09.021     Document Type: Article

References (28)

1. Scriver C.R., Kaufman S. Phenylalanine hydroxylase deficiency. The Metabolic and Molecular Basis of Inherited Disease 2001, 1667-1724. McGraw-Hill, New York. 8th ed. C.R. Scriver, A.L. Beaudet, W. Sly, D. Valle, B. Childs, B. Vogelstein (Eds.).
2. Kure S., Hou D.C., Ohura T., Iwamoto H., Suzuki S., Sugiyama N., Sakamoto O., Fujii K., Matsubara Y., Narisawa K. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J. Pediatr. 1999, 135:375-378.
3. Muntau A.C., Röschinger W., Habich M., Demmelmair H., Hoffmann B., Sommerhoff C.P., Roscher A.A. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N. Engl. J. Med. 2002, 347:2122-2132.
4. Levy H.L., Milanowski A., Chakrapani A., Cleary M., Lee P., Trefz F.K., Whitley C.B., Feillet F., Feigenbaum A.S., Bebchuk J.D., Christ-Schmidt H., Dorenbaum A., Sapropterin Research Group Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study. Lancet 2007, 11(370):504-510.
5. Lee P., Treacy E.P., Crombez E., Wasserstein M., Waber L., Wolff J., Wendel U., Dorenbaum A., Bebchuk J., Christ-Schmidt H., Seashore M., Giovannini M., Burton B.K., Morris A.A., Sapropterin Research Group Safety and efficacy of 22weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria. Am. J. Med. Genet. 2008, 146A:2851-2859.
6. Trefz F.K., Burton B.K., Longo N., Casanova M.M., Gruskin D.J., Dorenbaum A., Kakkis E.D., Crombez E.A., Grange D.K., Harmatz P., Lipson M.H., Milanowski A., Randolph L.M., Vockley J., Whitley C.B., Wolff J.A., Bebchuk J., Christ-Schmidt H., Hennermann J.B., Sapropterin Study Group Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study. J. Pediatr. 2009, 154:700-707.
7. F.K. Trefz, D. Scheible, G. Frauendienst-Egger, Long-term follow-up of patients with phenylketonuria receiving tetrahydrobiopterin treatment, J. Inherit. Metab. Dis. (2010, Mar 9. [Epub ahead of print]) (PMID: 20217238).
8. Burlina A., Blau N. Effect of BH(4) supplementation on phenylalanine tolerance. J. Inherit. Metab. Dis. 2009, 32:40-45.
9. B. Ziesch, J. Weigel, A. Thiele, U. Mütze, C. Rohde, U. Ceglarek, J. Thiery, W. Kiess, S. Beblo, Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of life, J. Inherit. Metab. Dis. (2012 Mar 6. [Epub ahead of print]) (PMID: 22391997).
10. Singh R.H., Quirk M.E., Douglas T.D., Brauchla M.C. BH(4) therapy impacts the nutrition status and intake in children with phenylketonuria: 2-year follow-up. J. Inherit. Metab. Dis. 2010, 33:689-695.
11. Hennermann J.B., Bührer C., Blau N., Vetter B., Mönch E. Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria. Mol. Genet. Metab. 2005, 86:S86-S90.
12. Bernegger C., Blau N. High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1,919 patients observed from 1988 to 2002. Mol. Genet. Metab. 2002, 77:304-313.
13. Zurflüh M.R., Zschocke J., Lindner M., Feillet F., Chery C., Burlina A., Stevens R.C., Thöny B., Blau N. Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Hum. Mutat. 2008, 29:167-175.
14. Burton B.K., Grange D.K., Milanowski A., Vockley G., Feillet F., Crombez E.A., Abadie V., Harding C.O., Cederbaum S., Dobbelaere D., Smith A., Dorenbaum A. The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study. J. Inherit. Metab. Dis. 2007, 30:700-707.
15. Cunningham A., Bausell H., Brown M., Chapman M., DeFouw K., Ernst S., McClure J., McCune H., O'Steen D., Pender A., Skrabal J., Wessel A., Jurecki E., Shediac R., Prasad S., Gillis J., Cederbaum S. Recommendations for the use of sapropterin in phenylketonuria. Mol. Genet. Metab. 2012, 106:269-276.
16. Guldberg P., Rey F., Zschocke J., Romano V., François B., Michiels L., Ullrich K., Hoffmann G.F., Burgard P., Schmidt H., Meli C., Riva E., Dianzani I., Ponzone A., Rey J., Güttler F. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am. J. Hum. Genet. 1998, 63:71-79.
17. Güttler F., Guldberg K.F. Mutations in the phenylalanine hydroxylase gene: genetic determinants for the phenotypic variability of hyperphenylalaninemia. Acta Paediatr. 1994, 407(Suppl.):46-56.
18. Blau N., Hennermann J.B., Langenbeck U., Lichter-Konecki U. Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies. Mol. Genet. Metab. 2011, 104(Suppl.):S2-S9.
19. Burgard P., Bremer H.J., Bührdel P., Clemens P.C., Mönch E., Przyrembel H., Trefz F.K., Ullrich K. Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur. J. Pediatr. 1999, 158:46-54.
20. Hennermann J.B., Vetter B., Wolf C., Windt E., Bührdel P., Seidel J., Mönch E., Kulozik A.E. Phenylketonuria and hyperphenylalaninemia in Eastern Germany: a characteristic molecular profile and 15 novel mutations. Hum. Mutat. 2000, 15:254-260.
21. van Spronsen F.J., van Rijn M., Dorgelo B., Hoeksma M., Bosch A.M., Mulder M.F., de Klerk J.B.C., de Koning T., Estela Rubio-Gozalbo M., de Vries M., Verkerk P.H. Phenylalanine tolerance can already reliably be assessed at the age of 2years in patients with PKU. J. Inherit. Metab. Dis. 2009, 32:27-31.
22. D-A-CH Empfehlung: Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung 2000, (Referenzwerte für die Nährstoffzufuhr: Umschau/Braus).
23. Staudigl M., Gersting S.W., Danecka M.K., Messing D.D., Woidy M., Pinkas D., Kemter K.F., Blau N., Muntau A.C. The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response. Hum. Mol. Genet. 2011, 20:2628-2641.
24. Burton B.K., Nowacka M., Hennermann J.B., Lipson M., Grange D.K., Chakrapani A., Trefz F., Dorenbaum A., Imperiale M., Kim S.S., Fernhoff P.M. Safety of extended treatment with sapropterin dihydrochloride in patients with phenylketonuria: results of a phase 3b study. Mol. Genet. Metab. 2011, 103:315-322.
25. Blau N., Bélanger-Quintana A., Demirkol M., Feillet F., Giovannini M., MacDonald A., Trefz F.K., van Spronsen F.J. Optimizing the use of sapropterin (BH(4)) in the management of phenylketonuria. Mol. Genet. Metab. 2009, 96:158-163.
26. Nielsen J.B., Nielsen K.E., Güttler F. Tetrahydrobiopterin responsiveness after extended loading test of 12 Danish PKU patients with the Y414C mutation. J. Inherit. Metab. Dis. 2010, 33:9-16.
27. Fiege B., Bonafé L., Ballhausen D., Baumgartner M., Thöny B., Meili D., Fiori L., Giovannini M., Blau N. Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study. Mol. Genet. Metab. 2005, 86(Suppl. 1):S91-S95.
28. Leandro J., Leandro P., Flatmark T. Heterotetrameric forms of human phenylalanine hydroxylase: co-expression of wild-type and mutant forms in a bicistronic system. Biochim. Biophys. Acta 2011, 1812:602-612.